Global Neurosurgery Drug Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
LPI (LP Information)' newest research report, the “Neurosurgery Drug Industry Forecast” looks at past sales and reviews total world Neurosurgery Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurosurgery Drug sales for 2023 through 2029. With Neurosurgery Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurosurgery Drug industry.
This Insight Report provides a comprehensive analysis of the global Neurosurgery Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurosurgery Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurosurgery Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurosurgery Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurosurgery Drug.
The global Neurosurgery Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurosurgery Drug players cover Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurosurgery Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Neurosurgery Drug market?
What factors are driving Neurosurgery Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurosurgery Drug market opportunities vary by end market size?
How does Neurosurgery Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
LPI (LP Information)' newest research report, the “Neurosurgery Drug Industry Forecast” looks at past sales and reviews total world Neurosurgery Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurosurgery Drug sales for 2023 through 2029. With Neurosurgery Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurosurgery Drug industry.
This Insight Report provides a comprehensive analysis of the global Neurosurgery Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurosurgery Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurosurgery Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurosurgery Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurosurgery Drug.
The global Neurosurgery Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurosurgery Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurosurgery Drug players cover Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurosurgery Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Solution
- Capsules
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- AstraZeneca
- Biogen
- Jhonson & Jhonson
- ABBVIE
- Takeda Pharmaceuticals
- UCB
- IPSEN
- Standigm
- BlueStar Genomic
- Tonix Pharmaceuticals
- BlackThorn Therapeutics
- Quentrix
- Wren Pharmaceuticals
What is the 10-year outlook for the global Neurosurgery Drug market?
What factors are driving Neurosurgery Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurosurgery Drug market opportunities vary by end market size?
How does Neurosurgery Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurosurgery Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neurosurgery Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neurosurgery Drug by Country/Region, 2018, 2022 & 2029
2.2 Neurosurgery Drug Segment by Type
2.2.1 Tablets
2.2.2 Solution
2.2.3 Capsules
2.2.4 Others
2.3 Neurosurgery Drug Sales by Type
2.3.1 Global Neurosurgery Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Neurosurgery Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neurosurgery Drug Sale Price by Type (2018-2023)
2.4 Neurosurgery Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Neurosurgery Drug Sales by Application
2.5.1 Global Neurosurgery Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Neurosurgery Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neurosurgery Drug Sale Price by Application (2018-2023)
3 GLOBAL NEUROSURGERY DRUG BY COMPANY
3.1 Global Neurosurgery Drug Breakdown Data by Company
3.1.1 Global Neurosurgery Drug Annual Sales by Company (2018-2023)
3.1.2 Global Neurosurgery Drug Sales Market Share by Company (2018-2023)
3.2 Global Neurosurgery Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Neurosurgery Drug Revenue by Company (2018-2023)
3.2.2 Global Neurosurgery Drug Revenue Market Share by Company (2018-2023)
3.3 Global Neurosurgery Drug Sale Price by Company
3.4 Key Manufacturers Neurosurgery Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurosurgery Drug Product Location Distribution
3.4.2 Players Neurosurgery Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROSURGERY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Neurosurgery Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Neurosurgery Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neurosurgery Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neurosurgery Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Neurosurgery Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neurosurgery Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neurosurgery Drug Sales Growth
4.4 APAC Neurosurgery Drug Sales Growth
4.5 Europe Neurosurgery Drug Sales Growth
4.6 Middle East & Africa Neurosurgery Drug Sales Growth
5 AMERICAS
5.1 Americas Neurosurgery Drug Sales by Country
5.1.1 Americas Neurosurgery Drug Sales by Country (2018-2023)
5.1.2 Americas Neurosurgery Drug Revenue by Country (2018-2023)
5.2 Americas Neurosurgery Drug Sales by Type
5.3 Americas Neurosurgery Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurosurgery Drug Sales by Region
6.1.1 APAC Neurosurgery Drug Sales by Region (2018-2023)
6.1.2 APAC Neurosurgery Drug Revenue by Region (2018-2023)
6.2 APAC Neurosurgery Drug Sales by Type
6.3 APAC Neurosurgery Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurosurgery Drug by Country
7.1.1 Europe Neurosurgery Drug Sales by Country (2018-2023)
7.1.2 Europe Neurosurgery Drug Revenue by Country (2018-2023)
7.2 Europe Neurosurgery Drug Sales by Type
7.3 Europe Neurosurgery Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurosurgery Drug by Country
8.1.1 Middle East & Africa Neurosurgery Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neurosurgery Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Neurosurgery Drug Sales by Type
8.3 Middle East & Africa Neurosurgery Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurosurgery Drug
10.3 Manufacturing Process Analysis of Neurosurgery Drug
10.4 Industry Chain Structure of Neurosurgery Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurosurgery Drug Distributors
11.3 Neurosurgery Drug Customer
12 WORLD FORECAST REVIEW FOR NEUROSURGERY DRUG BY GEOGRAPHIC REGION
12.1 Global Neurosurgery Drug Market Size Forecast by Region
12.1.1 Global Neurosurgery Drug Forecast by Region (2024-2029)
12.1.2 Global Neurosurgery Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurosurgery Drug Forecast by Type
12.7 Global Neurosurgery Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Neurosurgery Drug Product Portfolios and Specifications
13.1.3 Pfizer Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Neurosurgery Drug Product Portfolios and Specifications
13.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Neurosurgery Drug Product Portfolios and Specifications
13.3.3 Biogen Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Jhonson & Jhonson
13.4.1 Jhonson & Jhonson Company Information
13.4.2 Jhonson & Jhonson Neurosurgery Drug Product Portfolios and Specifications
13.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jhonson & Jhonson Main Business Overview
13.4.5 Jhonson & Jhonson Latest Developments
13.5 ABBVIE
13.5.1 ABBVIE Company Information
13.5.2 ABBVIE Neurosurgery Drug Product Portfolios and Specifications
13.5.3 ABBVIE Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ABBVIE Main Business Overview
13.5.5 ABBVIE Latest Developments
13.6 Takeda Pharmaceuticals
13.6.1 Takeda Pharmaceuticals Company Information
13.6.2 Takeda Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Takeda Pharmaceuticals Main Business Overview
13.6.5 Takeda Pharmaceuticals Latest Developments
13.7 UCB
13.7.1 UCB Company Information
13.7.2 UCB Neurosurgery Drug Product Portfolios and Specifications
13.7.3 UCB Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 UCB Main Business Overview
13.7.5 UCB Latest Developments
13.8 IPSEN
13.8.1 IPSEN Company Information
13.8.2 IPSEN Neurosurgery Drug Product Portfolios and Specifications
13.8.3 IPSEN Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IPSEN Main Business Overview
13.8.5 IPSEN Latest Developments
13.9 Standigm
13.9.1 Standigm Company Information
13.9.2 Standigm Neurosurgery Drug Product Portfolios and Specifications
13.9.3 Standigm Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Standigm Main Business Overview
13.9.5 Standigm Latest Developments
13.10 BlueStar Genomic
13.10.1 BlueStar Genomic Company Information
13.10.2 BlueStar Genomic Neurosurgery Drug Product Portfolios and Specifications
13.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BlueStar Genomic Main Business Overview
13.10.5 BlueStar Genomic Latest Developments
13.11 Tonix Pharmaceuticals
13.11.1 Tonix Pharmaceuticals Company Information
13.11.2 Tonix Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tonix Pharmaceuticals Main Business Overview
13.11.5 Tonix Pharmaceuticals Latest Developments
13.12 BlackThorn Therapeutics
13.12.1 BlackThorn Therapeutics Company Information
13.12.2 BlackThorn Therapeutics Neurosurgery Drug Product Portfolios and Specifications
13.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BlackThorn Therapeutics Main Business Overview
13.12.5 BlackThorn Therapeutics Latest Developments
13.13 Quentrix
13.13.1 Quentrix Company Information
13.13.2 Quentrix Neurosurgery Drug Product Portfolios and Specifications
13.13.3 Quentrix Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Quentrix Main Business Overview
13.13.5 Quentrix Latest Developments
13.14 Wren Pharmaceuticals
13.14.1 Wren Pharmaceuticals Company Information
13.14.2 Wren Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wren Pharmaceuticals Main Business Overview
13.14.5 Wren Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurosurgery Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neurosurgery Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neurosurgery Drug by Country/Region, 2018, 2022 & 2029
2.2 Neurosurgery Drug Segment by Type
2.2.1 Tablets
2.2.2 Solution
2.2.3 Capsules
2.2.4 Others
2.3 Neurosurgery Drug Sales by Type
2.3.1 Global Neurosurgery Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Neurosurgery Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neurosurgery Drug Sale Price by Type (2018-2023)
2.4 Neurosurgery Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Neurosurgery Drug Sales by Application
2.5.1 Global Neurosurgery Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Neurosurgery Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neurosurgery Drug Sale Price by Application (2018-2023)
3 GLOBAL NEUROSURGERY DRUG BY COMPANY
3.1 Global Neurosurgery Drug Breakdown Data by Company
3.1.1 Global Neurosurgery Drug Annual Sales by Company (2018-2023)
3.1.2 Global Neurosurgery Drug Sales Market Share by Company (2018-2023)
3.2 Global Neurosurgery Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Neurosurgery Drug Revenue by Company (2018-2023)
3.2.2 Global Neurosurgery Drug Revenue Market Share by Company (2018-2023)
3.3 Global Neurosurgery Drug Sale Price by Company
3.4 Key Manufacturers Neurosurgery Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurosurgery Drug Product Location Distribution
3.4.2 Players Neurosurgery Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROSURGERY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Neurosurgery Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Neurosurgery Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neurosurgery Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neurosurgery Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Neurosurgery Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neurosurgery Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neurosurgery Drug Sales Growth
4.4 APAC Neurosurgery Drug Sales Growth
4.5 Europe Neurosurgery Drug Sales Growth
4.6 Middle East & Africa Neurosurgery Drug Sales Growth
5 AMERICAS
5.1 Americas Neurosurgery Drug Sales by Country
5.1.1 Americas Neurosurgery Drug Sales by Country (2018-2023)
5.1.2 Americas Neurosurgery Drug Revenue by Country (2018-2023)
5.2 Americas Neurosurgery Drug Sales by Type
5.3 Americas Neurosurgery Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurosurgery Drug Sales by Region
6.1.1 APAC Neurosurgery Drug Sales by Region (2018-2023)
6.1.2 APAC Neurosurgery Drug Revenue by Region (2018-2023)
6.2 APAC Neurosurgery Drug Sales by Type
6.3 APAC Neurosurgery Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurosurgery Drug by Country
7.1.1 Europe Neurosurgery Drug Sales by Country (2018-2023)
7.1.2 Europe Neurosurgery Drug Revenue by Country (2018-2023)
7.2 Europe Neurosurgery Drug Sales by Type
7.3 Europe Neurosurgery Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurosurgery Drug by Country
8.1.1 Middle East & Africa Neurosurgery Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neurosurgery Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Neurosurgery Drug Sales by Type
8.3 Middle East & Africa Neurosurgery Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurosurgery Drug
10.3 Manufacturing Process Analysis of Neurosurgery Drug
10.4 Industry Chain Structure of Neurosurgery Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurosurgery Drug Distributors
11.3 Neurosurgery Drug Customer
12 WORLD FORECAST REVIEW FOR NEUROSURGERY DRUG BY GEOGRAPHIC REGION
12.1 Global Neurosurgery Drug Market Size Forecast by Region
12.1.1 Global Neurosurgery Drug Forecast by Region (2024-2029)
12.1.2 Global Neurosurgery Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurosurgery Drug Forecast by Type
12.7 Global Neurosurgery Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Neurosurgery Drug Product Portfolios and Specifications
13.1.3 Pfizer Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Neurosurgery Drug Product Portfolios and Specifications
13.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Neurosurgery Drug Product Portfolios and Specifications
13.3.3 Biogen Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Jhonson & Jhonson
13.4.1 Jhonson & Jhonson Company Information
13.4.2 Jhonson & Jhonson Neurosurgery Drug Product Portfolios and Specifications
13.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jhonson & Jhonson Main Business Overview
13.4.5 Jhonson & Jhonson Latest Developments
13.5 ABBVIE
13.5.1 ABBVIE Company Information
13.5.2 ABBVIE Neurosurgery Drug Product Portfolios and Specifications
13.5.3 ABBVIE Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ABBVIE Main Business Overview
13.5.5 ABBVIE Latest Developments
13.6 Takeda Pharmaceuticals
13.6.1 Takeda Pharmaceuticals Company Information
13.6.2 Takeda Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Takeda Pharmaceuticals Main Business Overview
13.6.5 Takeda Pharmaceuticals Latest Developments
13.7 UCB
13.7.1 UCB Company Information
13.7.2 UCB Neurosurgery Drug Product Portfolios and Specifications
13.7.3 UCB Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 UCB Main Business Overview
13.7.5 UCB Latest Developments
13.8 IPSEN
13.8.1 IPSEN Company Information
13.8.2 IPSEN Neurosurgery Drug Product Portfolios and Specifications
13.8.3 IPSEN Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IPSEN Main Business Overview
13.8.5 IPSEN Latest Developments
13.9 Standigm
13.9.1 Standigm Company Information
13.9.2 Standigm Neurosurgery Drug Product Portfolios and Specifications
13.9.3 Standigm Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Standigm Main Business Overview
13.9.5 Standigm Latest Developments
13.10 BlueStar Genomic
13.10.1 BlueStar Genomic Company Information
13.10.2 BlueStar Genomic Neurosurgery Drug Product Portfolios and Specifications
13.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BlueStar Genomic Main Business Overview
13.10.5 BlueStar Genomic Latest Developments
13.11 Tonix Pharmaceuticals
13.11.1 Tonix Pharmaceuticals Company Information
13.11.2 Tonix Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tonix Pharmaceuticals Main Business Overview
13.11.5 Tonix Pharmaceuticals Latest Developments
13.12 BlackThorn Therapeutics
13.12.1 BlackThorn Therapeutics Company Information
13.12.2 BlackThorn Therapeutics Neurosurgery Drug Product Portfolios and Specifications
13.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BlackThorn Therapeutics Main Business Overview
13.12.5 BlackThorn Therapeutics Latest Developments
13.13 Quentrix
13.13.1 Quentrix Company Information
13.13.2 Quentrix Neurosurgery Drug Product Portfolios and Specifications
13.13.3 Quentrix Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Quentrix Main Business Overview
13.13.5 Quentrix Latest Developments
13.14 Wren Pharmaceuticals
13.14.1 Wren Pharmaceuticals Company Information
13.14.2 Wren Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
13.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wren Pharmaceuticals Main Business Overview
13.14.5 Wren Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurosurgery Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neurosurgery Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Solution
Table 5. Major Players of Capsules
Table 6. Major Players of Others
Table 7. Global Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 8. Global Neurosurgery Drug Sales Market Share by Type (2018-2023)
Table 9. Global Neurosurgery Drug Revenue by Type (2018-2023) & ($ million)
Table 10. Global Neurosurgery Drug Revenue Market Share by Type (2018-2023)
Table 11. Global Neurosurgery Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 13. Global Neurosurgery Drug Sales Market Share by Application (2018-2023)
Table 14. Global Neurosurgery Drug Revenue by Application (2018-2023)
Table 15. Global Neurosurgery Drug Revenue Market Share by Application (2018-2023)
Table 16. Global Neurosurgery Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Neurosurgery Drug Sales by Company (2018-2023) & (K Units)
Table 18. Global Neurosurgery Drug Sales Market Share by Company (2018-2023)
Table 19. Global Neurosurgery Drug Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Neurosurgery Drug Revenue Market Share by Company (2018-2023)
Table 21. Global Neurosurgery Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Neurosurgery Drug Producing Area Distribution and Sales Area
Table 23. Players Neurosurgery Drug Products Offered
Table 24. Neurosurgery Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Neurosurgery Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Neurosurgery Drug Sales Market Share Geographic Region (2018-2023)
Table 29. Global Neurosurgery Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Neurosurgery Drug Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Neurosurgery Drug Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Neurosurgery Drug Sales Market Share by Country/Region (2018-2023)
Table 33. Global Neurosurgery Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Neurosurgery Drug Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 36. Americas Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 37. Americas Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 39. Americas Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 40. Americas Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 41. APAC Neurosurgery Drug Sales by Region (2018-2023) & (K Units)
Table 42. APAC Neurosurgery Drug Sales Market Share by Region (2018-2023)
Table 43. APAC Neurosurgery Drug Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Neurosurgery Drug Revenue Market Share by Region (2018-2023)
Table 45. APAC Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 46. APAC Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 47. Europe Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 48. Europe Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 49. Europe Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 51. Europe Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 52. Europe Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Neurosurgery Drug
Table 60. Key Market Challenges & Risks of Neurosurgery Drug
Table 61. Key Industry Trends of Neurosurgery Drug
Table 62. Neurosurgery Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Neurosurgery Drug Distributors List
Table 65. Neurosurgery Drug Customer List
Table 66. Global Neurosurgery Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Neurosurgery Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Neurosurgery Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Neurosurgery Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Neurosurgery Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Neurosurgery Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Neurosurgery Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Neurosurgery Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Pfizer Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Neurosurgery Drug Product Portfolios and Specifications
Table 82. Pfizer Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. AstraZeneca Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Neurosurgery Drug Product Portfolios and Specifications
Table 87. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Biogen Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Biogen Neurosurgery Drug Product Portfolios and Specifications
Table 92. Biogen Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Biogen Main Business
Table 94. Biogen Latest Developments
Table 95. Jhonson & Jhonson Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Jhonson & Jhonson Neurosurgery Drug Product Portfolios and Specifications
Table 97. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Jhonson & Jhonson Main Business
Table 99. Jhonson & Jhonson Latest Developments
Table 100. ABBVIE Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. ABBVIE Neurosurgery Drug Product Portfolios and Specifications
Table 102. ABBVIE Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. ABBVIE Main Business
Table 104. ABBVIE Latest Developments
Table 105. Takeda Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Takeda Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 107. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Takeda Pharmaceuticals Main Business
Table 109. Takeda Pharmaceuticals Latest Developments
Table 110. UCB Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. UCB Neurosurgery Drug Product Portfolios and Specifications
Table 112. UCB Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. UCB Main Business
Table 114. UCB Latest Developments
Table 115. IPSEN Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. IPSEN Neurosurgery Drug Product Portfolios and Specifications
Table 117. IPSEN Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. IPSEN Main Business
Table 119. IPSEN Latest Developments
Table 120. Standigm Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Standigm Neurosurgery Drug Product Portfolios and Specifications
Table 122. Standigm Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Standigm Main Business
Table 124. Standigm Latest Developments
Table 125. BlueStar Genomic Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. BlueStar Genomic Neurosurgery Drug Product Portfolios and Specifications
Table 127. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. BlueStar Genomic Main Business
Table 129. BlueStar Genomic Latest Developments
Table 130. Tonix Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Tonix Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 132. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Tonix Pharmaceuticals Main Business
Table 134. Tonix Pharmaceuticals Latest Developments
Table 135. BlackThorn Therapeutics Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. BlackThorn Therapeutics Neurosurgery Drug Product Portfolios and Specifications
Table 137. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. BlackThorn Therapeutics Main Business
Table 139. BlackThorn Therapeutics Latest Developments
Table 140. Quentrix Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Quentrix Neurosurgery Drug Product Portfolios and Specifications
Table 142. Quentrix Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Quentrix Main Business
Table 144. Quentrix Latest Developments
Table 145. Wren Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Wren Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 147. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Wren Pharmaceuticals Main Business
Table 149. Wren Pharmaceuticals Latest Developments
Table 1. Neurosurgery Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neurosurgery Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Solution
Table 5. Major Players of Capsules
Table 6. Major Players of Others
Table 7. Global Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 8. Global Neurosurgery Drug Sales Market Share by Type (2018-2023)
Table 9. Global Neurosurgery Drug Revenue by Type (2018-2023) & ($ million)
Table 10. Global Neurosurgery Drug Revenue Market Share by Type (2018-2023)
Table 11. Global Neurosurgery Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 13. Global Neurosurgery Drug Sales Market Share by Application (2018-2023)
Table 14. Global Neurosurgery Drug Revenue by Application (2018-2023)
Table 15. Global Neurosurgery Drug Revenue Market Share by Application (2018-2023)
Table 16. Global Neurosurgery Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Neurosurgery Drug Sales by Company (2018-2023) & (K Units)
Table 18. Global Neurosurgery Drug Sales Market Share by Company (2018-2023)
Table 19. Global Neurosurgery Drug Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Neurosurgery Drug Revenue Market Share by Company (2018-2023)
Table 21. Global Neurosurgery Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Neurosurgery Drug Producing Area Distribution and Sales Area
Table 23. Players Neurosurgery Drug Products Offered
Table 24. Neurosurgery Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Neurosurgery Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Neurosurgery Drug Sales Market Share Geographic Region (2018-2023)
Table 29. Global Neurosurgery Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Neurosurgery Drug Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Neurosurgery Drug Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Neurosurgery Drug Sales Market Share by Country/Region (2018-2023)
Table 33. Global Neurosurgery Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Neurosurgery Drug Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 36. Americas Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 37. Americas Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 39. Americas Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 40. Americas Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 41. APAC Neurosurgery Drug Sales by Region (2018-2023) & (K Units)
Table 42. APAC Neurosurgery Drug Sales Market Share by Region (2018-2023)
Table 43. APAC Neurosurgery Drug Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Neurosurgery Drug Revenue Market Share by Region (2018-2023)
Table 45. APAC Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 46. APAC Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 47. Europe Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 48. Europe Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 49. Europe Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 51. Europe Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 52. Europe Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Neurosurgery Drug Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Neurosurgery Drug Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Neurosurgery Drug Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Neurosurgery Drug Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Neurosurgery Drug Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Neurosurgery Drug Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Neurosurgery Drug
Table 60. Key Market Challenges & Risks of Neurosurgery Drug
Table 61. Key Industry Trends of Neurosurgery Drug
Table 62. Neurosurgery Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Neurosurgery Drug Distributors List
Table 65. Neurosurgery Drug Customer List
Table 66. Global Neurosurgery Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Neurosurgery Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Neurosurgery Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Neurosurgery Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Neurosurgery Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Neurosurgery Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Neurosurgery Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Neurosurgery Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Neurosurgery Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Neurosurgery Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Pfizer Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Neurosurgery Drug Product Portfolios and Specifications
Table 82. Pfizer Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. AstraZeneca Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Neurosurgery Drug Product Portfolios and Specifications
Table 87. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Biogen Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Biogen Neurosurgery Drug Product Portfolios and Specifications
Table 92. Biogen Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Biogen Main Business
Table 94. Biogen Latest Developments
Table 95. Jhonson & Jhonson Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Jhonson & Jhonson Neurosurgery Drug Product Portfolios and Specifications
Table 97. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Jhonson & Jhonson Main Business
Table 99. Jhonson & Jhonson Latest Developments
Table 100. ABBVIE Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. ABBVIE Neurosurgery Drug Product Portfolios and Specifications
Table 102. ABBVIE Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. ABBVIE Main Business
Table 104. ABBVIE Latest Developments
Table 105. Takeda Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Takeda Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 107. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Takeda Pharmaceuticals Main Business
Table 109. Takeda Pharmaceuticals Latest Developments
Table 110. UCB Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. UCB Neurosurgery Drug Product Portfolios and Specifications
Table 112. UCB Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. UCB Main Business
Table 114. UCB Latest Developments
Table 115. IPSEN Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. IPSEN Neurosurgery Drug Product Portfolios and Specifications
Table 117. IPSEN Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. IPSEN Main Business
Table 119. IPSEN Latest Developments
Table 120. Standigm Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Standigm Neurosurgery Drug Product Portfolios and Specifications
Table 122. Standigm Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Standigm Main Business
Table 124. Standigm Latest Developments
Table 125. BlueStar Genomic Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. BlueStar Genomic Neurosurgery Drug Product Portfolios and Specifications
Table 127. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. BlueStar Genomic Main Business
Table 129. BlueStar Genomic Latest Developments
Table 130. Tonix Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Tonix Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 132. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Tonix Pharmaceuticals Main Business
Table 134. Tonix Pharmaceuticals Latest Developments
Table 135. BlackThorn Therapeutics Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. BlackThorn Therapeutics Neurosurgery Drug Product Portfolios and Specifications
Table 137. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. BlackThorn Therapeutics Main Business
Table 139. BlackThorn Therapeutics Latest Developments
Table 140. Quentrix Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Quentrix Neurosurgery Drug Product Portfolios and Specifications
Table 142. Quentrix Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Quentrix Main Business
Table 144. Quentrix Latest Developments
Table 145. Wren Pharmaceuticals Basic Information, Neurosurgery Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Wren Pharmaceuticals Neurosurgery Drug Product Portfolios and Specifications
Table 147. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Wren Pharmaceuticals Main Business
Table 149. Wren Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurosurgery Drug
Figure 2. Neurosurgery Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurosurgery Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Neurosurgery Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neurosurgery Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Solution
Figure 11. Product Picture of Capsules
Figure 12. Product Picture of Others
Figure 13. Global Neurosurgery Drug Sales Market Share by Type in 2022
Figure 14. Global Neurosurgery Drug Revenue Market Share by Type (2018-2023)
Figure 15. Neurosurgery Drug Consumed in Hospital
Figure 16. Global Neurosurgery Drug Market: Hospital (2018-2023) & (K Units)
Figure 17. Neurosurgery Drug Consumed in Clinic
Figure 18. Global Neurosurgery Drug Market: Clinic (2018-2023) & (K Units)
Figure 19. Neurosurgery Drug Consumed in Others
Figure 20. Global Neurosurgery Drug Market: Others (2018-2023) & (K Units)
Figure 21. Global Neurosurgery Drug Sales Market Share by Application (2022)
Figure 22. Global Neurosurgery Drug Revenue Market Share by Application in 2022
Figure 23. Neurosurgery Drug Sales Market by Company in 2022 (K Units)
Figure 24. Global Neurosurgery Drug Sales Market Share by Company in 2022
Figure 25. Neurosurgery Drug Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Neurosurgery Drug Revenue Market Share by Company in 2022
Figure 27. Global Neurosurgery Drug Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Neurosurgery Drug Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 30. Americas Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 31. APAC Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 32. APAC Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 33. Europe Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 34. Europe Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 37. Americas Neurosurgery Drug Sales Market Share by Country in 2022
Figure 38. Americas Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 39. Americas Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 40. Americas Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 41. United States Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Neurosurgery Drug Sales Market Share by Region in 2022
Figure 46. APAC Neurosurgery Drug Revenue Market Share by Regions in 2022
Figure 47. APAC Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 48. APAC Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 49. China Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Neurosurgery Drug Sales Market Share by Country in 2022
Figure 57. Europe Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 58. Europe Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 59. Europe Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 60. Germany Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Neurosurgery Drug Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 69. Egypt Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurosurgery Drug in 2022
Figure 75. Manufacturing Process Analysis of Neurosurgery Drug
Figure 76. Industry Chain Structure of Neurosurgery Drug
Figure 77. Channels of Distribution
Figure 78. Global Neurosurgery Drug Sales Market Forecast by Region (2024-2029)
Figure 79. Global Neurosurgery Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Neurosurgery Drug Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Neurosurgery Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Neurosurgery Drug Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Neurosurgery Drug Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Neurosurgery Drug
Figure 2. Neurosurgery Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurosurgery Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Neurosurgery Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neurosurgery Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Solution
Figure 11. Product Picture of Capsules
Figure 12. Product Picture of Others
Figure 13. Global Neurosurgery Drug Sales Market Share by Type in 2022
Figure 14. Global Neurosurgery Drug Revenue Market Share by Type (2018-2023)
Figure 15. Neurosurgery Drug Consumed in Hospital
Figure 16. Global Neurosurgery Drug Market: Hospital (2018-2023) & (K Units)
Figure 17. Neurosurgery Drug Consumed in Clinic
Figure 18. Global Neurosurgery Drug Market: Clinic (2018-2023) & (K Units)
Figure 19. Neurosurgery Drug Consumed in Others
Figure 20. Global Neurosurgery Drug Market: Others (2018-2023) & (K Units)
Figure 21. Global Neurosurgery Drug Sales Market Share by Application (2022)
Figure 22. Global Neurosurgery Drug Revenue Market Share by Application in 2022
Figure 23. Neurosurgery Drug Sales Market by Company in 2022 (K Units)
Figure 24. Global Neurosurgery Drug Sales Market Share by Company in 2022
Figure 25. Neurosurgery Drug Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Neurosurgery Drug Revenue Market Share by Company in 2022
Figure 27. Global Neurosurgery Drug Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Neurosurgery Drug Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 30. Americas Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 31. APAC Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 32. APAC Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 33. Europe Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 34. Europe Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Neurosurgery Drug Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Neurosurgery Drug Revenue 2018-2023 ($ Millions)
Figure 37. Americas Neurosurgery Drug Sales Market Share by Country in 2022
Figure 38. Americas Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 39. Americas Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 40. Americas Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 41. United States Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Neurosurgery Drug Sales Market Share by Region in 2022
Figure 46. APAC Neurosurgery Drug Revenue Market Share by Regions in 2022
Figure 47. APAC Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 48. APAC Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 49. China Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Neurosurgery Drug Sales Market Share by Country in 2022
Figure 57. Europe Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 58. Europe Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 59. Europe Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 60. Germany Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Neurosurgery Drug Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Neurosurgery Drug Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Neurosurgery Drug Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Neurosurgery Drug Sales Market Share by Application (2018-2023)
Figure 69. Egypt Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Neurosurgery Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurosurgery Drug in 2022
Figure 75. Manufacturing Process Analysis of Neurosurgery Drug
Figure 76. Industry Chain Structure of Neurosurgery Drug
Figure 77. Channels of Distribution
Figure 78. Global Neurosurgery Drug Sales Market Forecast by Region (2024-2029)
Figure 79. Global Neurosurgery Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Neurosurgery Drug Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Neurosurgery Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Neurosurgery Drug Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Neurosurgery Drug Revenue Market Share Forecast by Application (2024-2029)
